ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 3-iodothyronamine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

44 träffar

Bibliografisk träff 2019-05-08

N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.

Landucci E, Gencarelli M, Mazzantini C, Laurino A, Pellegrini-Giampietro DE, Raimondi L.

Neurochem Int · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuint.2019.05.004

Bibliografisk träff 2019-04-01

Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure.

la Cour JL, Christensen HM, Köhrle J, Lehmphul I, Kistorp C, Nygaard B, Faber J.

J Clin Endocrinol Metab · journal article · DOI 10.1210/jc.2018-01466

Bibliografisk träff 2018-11-22

Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T<sub>1</sub>AM) in Human Corneal Keratocytes.

Türker E, Garreis F, Khajavi N, Reinach PS, Joshi P, Brockmann T, Lucius A, Ljubojevic N, Turan E, Cooper D, Schick F, Reinholz R, Pleyer U, Köhrle J, Mergler S.

Front Endocrinol (Lausanne) · research-article; journal article · DOI 10.3389/fendo.2018.00670

Bibliografisk träff 2018-11-01

3-Iodothyronamine Acting through an Anti-Apoptotic Mechanism Is Neuroprotective Against Spinal Cord Injury in Rats.

Lv J, Liao J, Tan W, Yang L, Shi X, Zhang H, Chen L, Wang S, Li Q.

Ann Clin Lab Sci · journal article

Bibliografisk träff 2018-05-22

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.

Assadi-Porter FM, Reiland H, Sabatini M, Lorenzini L, Carnicelli V, Rogowski M, Selen Alpergin ES, Tonelli M, Ghelardoni S, Saba A, Zucchi R, Chiellini G.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms19051535

Bibliografisk träff 2018-03-12

The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.

Bräunig J, Dinter J, Höfig CS, Paisdzior S, Szczepek M, Scheerer P, Rosowski M, Mittag J, Kleinau G, Biebermann H.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2018.00222

Bibliografisk träff 2017-12-12

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.

Bellusci L, Laurino A, Sabatini M, Sestito S, Lenzi P, Raimondi L, Rapposelli S, Biagioni F, Fornai F, Salvetti A, Rossi L, Zucchi R, Chiellini G.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2017.00905

Bibliografisk träff 2017-07-19

The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice.

Laurino A, Lucenteforte E, De Siena G, Raimondi L.

Horm Behav · journal article · DOI 10.1016/j.yhbeh.2017.07.003

Bibliografisk träff 2017-06-01

3-Iodothyronamine Induces Tail Vasodilation Through Central Action in Male Mice.

Gachkar S, Oelkrug R, Martinez-Sanchez N, Rial-Pensado E, Warner A, Hoefig CS, López M, Mittag J.

Endocrinology · research support, non-u.s. gov't; journal article · DOI 10.1210/en.2016-1951

Bibliografisk träff 2016-11-02

3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors.

Laurino A, Matucci R, Vistoli G, Raimondi L.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2016.10.027

Bibliografisk träff 2016-10-25

Circulating 3-T1AM and 3,5-T2 in Critically Ill Patients: A Cross-Sectional Observational Study.

Langouche L, Lehmphul I, Perre SV, Köhrle J, Van den Berghe G.

Thyroid · research support, non-u.s. gov't; journal article; observational study · DOI 10.1089/thy.2016.0214

Bibliografisk träff 2015-04-15

3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.

Dinter J, Mühlhaus J, Jacobi SF, Wienchol CL, Cöster M, Meister J, Hoefig CS, Müller A, Köhrle J, Grüters A, Krude H, Mittag J, Schöneberg T, Kleinau G, Biebermann H.

J Mol Endocrinol · research support, non-u.s. gov't; journal article · DOI 10.1530/jme-15-0003

Bibliografisk träff 2011-04-13

Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.

Hoefig CS, Köhrle J, Brabant G, Dixit K, Yap B, Strasburger CJ, Wu Z.

J Clin Endocrinol Metab · research support, non-u.s. gov't; journal article · DOI 10.1210/jc.2010-2680

Bibliografisk träff 2004-05-16

3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.

Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK.

Nat Med · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1038/nm1051